glp 1 and sarcopenia in the Era of GLP-1 Medications GLP‐1 receptor agonists and muscle

Some individuals can wean off faster than others, especially if they are on a lower dose and have not been on the GLP-1 receptor agonist for long, in comparison to patients on the maximum dose and have been on the drug long-term

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP

But they also create a nutritional paradox

Clinicians should emphasize that GLP-1 medications complement but do not replace evidence-based lipid management with statins

Dignass, A

Metabolic Disorders and Insulin Sensitivity : GLP-1 R activation has been shown to improve insulin sensitivity and glucose metabolism , making it a valuable tool in research on metabolic syndrome , pre-diabetes , and insulin resistance